Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorThe First Affiliated Hospital with Nanjing Medical University

About this trial

The goal of this clinical trial is to learn about breast cancer patients. The main questions it aims to answer are:

* Does Aerobic Dance During Chemotherapy Improve Cognitive Function in Breast Cancer Patients? * Does the efficacy of aerobic dance differ from fast walking of equal intensity? Recruited patients will be randomly assigned to three groups: (1) aerobic dance group, (2) fast walking group, and (3) usual care group.

The aerobic dance and fast-walking groups participated in supervised exercise lasting 50 minutes thrice a week for 12 weeks.

The goal of this study's findings is to develop practical strategies for managing breast cancer-related cognitive impairment.

Eligibility criteria

Qualifiers

18-65 years old

Newly diagnosed, histologically confirmed, resected stage I-IIIa BC

Scheduled for chemotherapy with Epirubicin+ Cyclophosphamide (EC) regimen

Presence of objective cognitive decline

Disqualifiers

Regular exercise habits (exercise at moderate intensity for 30 minutes a day, 3 days a week, for at least 3 months.),

Motor dysfunction

Alzheimer's disease

Vascular dementia

Trial design

Treatments tested in this trial

  • Aerobic dance
  • Fast-walking

Treatment groups

90 Participants
are divided into 3 treatment groups